Neogenomics Inc.

Market cap: $1,974,127,303

Exchange: NAS

Sector: Health Services

NeoGenomics, Inc. is a clinical laboratory company, which specializes in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Key Statistics

Company Name

Neogenomics Inc.

Average Volume (10 days)

619,839

Average Volume (30 days)

1,127,402

Moving Average (50 days)

$15.38

Moving Average (200 days)

$15.54

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

-22.4414

Market Cap

1,974,127,303

Shares Outstanding

127,610,039

52-Week High Split Adjust Only

21.22

52-Week Low Split Adjust Only

11.03

Employee Count

1,345

Beta

1.7136

Next Earnings Date

2024-05-08

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.02%

Past 30 days

0.08%

Past 3 months

-0.19%

Past 6 months

0.13%

Past year

-0.12%

Past 2 years

-0.03%

Past 5 years

-0.21%

Max % Change

9.18%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Neogenomics Inc.NEO10.665.73-224.110.6610.49
Peer AvgN/A0.892.1710.30.890.99
Laboratory Corp. Of America HoldingsLH1.752.6812.21.751.99
Quest Diagnostics, Inc.DGX1.662.5511.91.661.93
Radnet IncRDNT1.267.5748.11.261.82
Enzo Biochem, Inc.ENZ1.542.40n/a1.541.20
Psychemedics Corp.PMDn/an/an/an/an/a
Brilliant Acquisition CorpBRLIn/an/an/an/an/a